Antimicrobial Susceptibilities of Peptostreptococcus anaerobius and the Newly Described Peptostreptococcus stomatis Isolated from Various Human Sources

Antimicrobial Agents and Chemotherapy
2007.0

Abstract

Peptostreptococcus anaerobius sensu lato, currently including two closely related species, P. anaerobius and P. stomatis, is known to be more resistant than other gram-positive anaerobic cocci. We reidentified potential Peptostreptococcus isolates and tested their susceptibilities to eight antimicrobials. Notably, P. anaerobius had constantly higher values for the MIC at which 50% of the isolates are inhibited (MIC(50)) and the MIC(90) than P. stomatis.

Knowledge Graph

Similar Paper

Antimicrobial Susceptibilities of Peptostreptococcus anaerobius and the Newly Described Peptostreptococcus stomatis Isolated from Various Human Sources
Antimicrobial Agents and Chemotherapy 2007.0
Antimicrobial Susceptibilities and Clinical Sources ofDialisterSpecies
Antimicrobial Agents and Chemotherapy 2007.0
Resistance of Porphyromonas gingivalis ATCC 33277 to Direct Killing by Antimicrobial Peptides Is Protease Independent
Antimicrobial Agents and Chemotherapy 2008.0
Antimicrobial Susceptibility Patterns for Recent Clinical Isolates of Anaerobic Bacteria in South Korea
Antimicrobial Agents and Chemotherapy 2010.0
Increasing Trends in Antimicrobial Resistance among Clinically Important Anaerobes and Bacteroides fragilis Isolates Causing Nosocomial Infections: Emerging Resistance to Carbapenems
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Activities of the Lipopeptides Palmitoyl (Pal)-Lys-Lys-NH <sub>2</sub> and Pal-Lys-Lys Alone and in Combination with Antimicrobial Agents against Multiresistant Gram-Positive Cocci
Antimicrobial Agents and Chemotherapy 2007.0
Susceptibilities of 23 Desulfovibrio Isolates from Humans
Antimicrobial Agents and Chemotherapy 2009.0
Efficacy of the De Novo-Derived Antimicrobial Peptide WLBU2 against Oral Bacteria
Antimicrobial Agents and Chemotherapy 2007.0
Cervinomycin A1 and A2, new antibiotics active against anaerobes, produced by Streptomyces cervinus sp. nov.
The Journal of Antibiotics 1982.0
Prevalence of Serotype 19A Streptococcus pneumoniae among Isolates from U.S. Children in 2005-2006 and Activity of Faropenem
Antimicrobial Agents and Chemotherapy 2008.0